Drug Use Investigation for Toviaz
Phase of Trial: Phase IV
Latest Information Update: 08 Apr 2017
Price : $35 *
At a glance
- Drugs Fesoterodine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors Pfizer
- 31 Aug 2018 Biomarkers information updated
- 10 Aug 2016 Status changed from active, no longer recruiting to completed.
- 12 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Jul 2016.